Newswire

MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has unveiled the first bio-based solvent portfolio tailored for high-performance liquid chromatography (HPLC). These innovative solvents, produced from renewable feedstocks, are designed to reduce CO2 emissions by an average of 25.9% compared to traditional fossil-fuel-based HPLC-grade solvents, all while maintaining the high performance essential for rigorous analytical processes.

According to Karen Madden, Chief Technology Officer at MilliporeSigma, this new portfolio addresses the growing demand for environmentally sustainable solutions without sacrificing analytical quality. The bio-based solvents are compatible with existing HPLC and liquid chromatography mass spectrometry (LC-MS) methods, facilitating their integration into current laboratory practices and regulatory environments.

By providing drop-in replacements for conventional solvents like acetonitrile, methanol, and ethanol, MilliporeSigma enables laboratories to transition smoothly to greener alternatives, minimizing the need for extensive method redevelopment. This launch not only reinforces the company’s commitment to sustainable science but also positions it strategically within the evolving landscape of analytical chemistry, where environmental considerations are increasingly paramount.

For investors and analysts: See in seconds what each company actually manufactures, together with its certificates and compliance status. This isn’t marketing language — it’s factual data on APIs, FDFs, dossiers, and direct producer contacts.
Open the full market picture for your next decision →